Mercury Meditek Systems Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
- Revenue Growth 28.55%
- Profit Growth 18.87%
- Ebitda 27.42%
- Net Worth 8.58%
- Total Assets 3.01%
About Mercury Meditek Systems
Mercury Meditek Systems Private Limited (MMSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 June 2010 and has a history of 14 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹7.00 M.
Sunil Bhayana, Anil Bhayana, and Sarita Bhayana serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15122DL2010PTC204730
-
Company No.
204730
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Mercury Meditek Systems Private Limited offer?
Mercury Meditek Systems Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Cardiac Drugs, Sexual Wellness Products, Fertility Enhancer, Anti Infective Drugs & Medicines, Antibiotic Injection.
Who are the key members and board of directors at Mercury Meditek Systems?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Bhayana
|
Director | 25-Jun-2010 | Current |
|
Anil Bhayana
|
Director | 01-Jul-2014 | Current |
|
Sarita Bhayana
|
Director | 25-Jun-2010 | Current |
Financial Performance of Mercury Meditek Systems.
Mercury Meditek Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.55% increase. The company also saw a substantial improvement in profitability, with a 18.87% increase in profit. The company's net worth moved up by a moderate rise of 8.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mercury Meditek Systems?
In 2021, Mercury Meditek Systems had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medorah Meditek Private LimitedSunil Bhayana is a mutual person
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2014 | State Bank Of India | ₹7.00 M | Open |
How Many Employees Work at Mercury Meditek Systems?
Unlock and access historical data on people associated with Mercury Meditek Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mercury Meditek Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercury Meditek Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.